Skip to main content
. 2013 Jun 25;15(9):630–636. doi: 10.1111/jch.12155

Table 2.

Clinical Patient Characteristics and FMD Parameters

Covariates FMD AUC120, mm × s P Value ΔFMD, % P Value
Sex
Male (n=131) 9.3±6.9 .799 4.9±4.1 .435
Female (n=126) 9.5±8.0 5.3±5.1
Current smoker
Yes (n=29) 11.0±7.2 .205 5.5±3.8 .536
No (n=228) 9.2±7.5 4.9±4.6
Regular drinker
Yes (n=52) 11.0±6.7 .085 4.7±4.1 .388
No (n=205) 9.0±7.6 5.2±4.8
Hyperlipidemia
Present (n=85) 10.2±8.9 .229 5.6±4.4 .097
Absent (n=172) 9.0±6.6 4.7±4.7
Diabetes mellitus
Present (n=58) 10.1±8.7 .413 5.6±4.1 .327
Absent (n=199) 9.2±7.0 4.9±4.7
Antihypertensive medication
Present (n=196) 9.0±6.9 .131 4.9±4.2 .179
Absent (n=61) 10.7±8.8 5.8±5.7
Statin use
Present (n=64) 10.2±8.9 .323 5.5±4.1 .414
Absent (n=193) 9.1±6.9 5.0±4.8

Values are expressed as mean±standard deviation or percentage of patients. Abbreviations: ΔFMD, flow‐mediated vasodilation (FMD) magnitude in percentage change in peak diameter from baseline; FMD‐AUC120, integrated FMD response calculated as the area under the dilation curve during the 120‐second dilation period after cuff deflation.